Post by
Dragon1 on May 31, 2021 6:39pm
anything going on
Next financials or any kind of news,we seem to be heading for a very sluggish summer.
Comment by
dart321 on Jun 03, 2021 12:04pm
Hi Wallpaper2, one only has to look at the EPS of -0.22 cents per share and a PE/ratio of -41.1 then look at future sales possibilities. The truth is there for all to see,this was a perfect short and still is. My guess the bottom will be 2 bucks give or take a few cents.
Comment by
Driven on Jun 04, 2021 11:50am
This post has been removed in accordance with Community Policy
Comment by
DanChilds on Jun 04, 2021 11:43pm
How do you feel about their CSO just resigning? I don't love in that in that anouncement, they say they are a "leader" in therapeutics in the same breadth that they admit they lost Dr. Adiche. More like they have the potential to be a player if and when they get a single therapeutic product, which seems less likely now.
Comment by
Driven on Jun 05, 2021 11:33am
This post has been removed in accordance with Community Policy
Comment by
wallpaper2 on Jun 05, 2021 2:42pm
Same group, same pattern, repeated over and over. Shameful and no morals. If you are part of the inside group you made a ton. General public strung along in my opinion. Disappointed in Jennifer.
Comment by
dart321 on Jun 06, 2021 12:14pm
wally, the PE/Ratio and the EPS tell the truth, a company can not hide that. I see no pathway to any change going forward it's the reason I shorted this stock between $25 and $26, it was the second time in my life I ever shorted a stock. I covered a short time ago but it was hard to decide to do it. Still think it drops to $2/$3.
Comment by
Playoff on Jun 07, 2021 1:13pm
This post has been removed in accordance with Community Policy
Comment by
007dave on Jun 07, 2021 2:59pm
Which master pumper are you referring to. IPA has been around along time and 90% of the executives are women and science based. Which is one reason the stock is down right now. IPA needs more market people that understand capital markets. They're on the NASDAQ now and need to step up their game.